Elder Pharmaceuticals Limited Q1, Q2, Q3, Q4, FY 2017-18, FY 2016-17 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Elder Pharmaceuticals Limited Company Profile :

Elder Pharmaceuticals Limited is an Indian pharmaceuticals company engaged in manufacturing and marketing of prescription pharmaceutical brands, surgical and medical devices.

Company has largest presence in three therapeutic segments, Women’s Healthcare, Wound Care and Nutraceuticals.

Company has 6 manufacturing plants in India & one in Nepal. It manufacture various dosage forms like tablets, capsules, syrups, injectables, topical creams and ointments.


Elder Pharmaceuticals ResultsBSE Code : 532322
NSE Symbol : ELDERPHARM
ISIN No. : INE975A01015
Industry : Pharmaceuticals
Face Value : Rs. 10.00


If you are an investor who has shares of Elder Pharmaceuticals or you are an stock market analyst then i am sure you might for Quarterly Results of Elder Pharmaceuticals.

In this article you will find Q1, Q2, Q3, Q4 and FY 2017-18 Results of Elder Pharmaceuticals. That’s not all, you can compare those results with previous year i.e., FY 2016-17 Results of Elder Pharmaceuticals.

Elder Pharmaceuticals Q1 Results 2017-18 :

Elder Pharmaceuticals will announce its Q1 FY 2017-18 Results in August 2017. Will soon update the below mentioned table.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Elder Pharmaceuticals will announce its Q2 FY 2017-18 Results in the month of October 2017.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Elder Pharmaceuticals will announce its Q3 FY 2017-18 Results in the month of January 2018.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Elder Pharmaceuticals will announce its Q4 FY 2017-18 Results in the month of April 2018.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Elder Pharmaceuticals will announce its FY 2017-18 Results in the month of April 2018.

(Values in Cr.) FY 2017-18 Standalone FY 2017-18 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Elder Pharmaceuticals Previous Year’s Results (FY 2016-17) :

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : If you like this information about Elder Pharmaceuticals Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.